Abstract
A number of isoindolo[l ,2- b]quinazolines and some benzo[4,5]isoquinolino[l,2- b]quinazolines as structural modification analogues of the antitumor compound batracylin were synthesized and evaluated against HL-60 cell growth and in topoisomerase II-mediated DNA cleavage assays. Of the compounds studied, 10,12-dihydro-7,8-methy lenedioxyisoindolo[ 1,2- b] quinazolin-12(10 H)-one 1d, 2-amino-10,12-dihydroisoindolo[l ,2- b]quinazolin- 12(10 H)-one 1p, and 2-amino-7,8-methylenedioxy-10,12-dihydroisoindolo[l ,2- b]quinazolin-12(10 H)-one 1ab exhibited good inhibitory activities against HL-60 cell lines as well as induction of topo II-mediated DNA cleavage activities.
Original language | English |
---|---|
Pages (from-to) | 918-923 |
Number of pages | 6 |
Journal | Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists |
Volume | 10 |
Issue number | 6 |
DOIs | |
Publication status | Published - Jun 1993 |
Externally published | Yes |
Keywords
- DNA topoisomerase
- colon adenocarcinoma 38
- cytotoxicity
- isoindolo[l,2- b]quinazolines
- structure–activity relationship
ASJC Scopus subject areas
- Pharmacology (medical)
- Molecular Medicine
- Biotechnology
- Pharmacology
- Pharmaceutical Science
- Organic Chemistry